We are live on ! Find out more
Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $63.9B
1-Year Est. Return 45.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Fund
S&P 500
This Quarter Est. Return
+2.28%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.07%
AUM
$38.1B
AUM Growth
Cap. Flow
+$38.4B
Cap. Flow %
100.8%
Top 10 Hldgs %
11.4%
Holding
2,756
New
2,750
Increased
Reduced
Closed

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$671M
2
MCD icon
McDonald's
MCD
+$636M
3
TSM icon
TSMC
TSM
+$515M
4
NVO
Novo Nordisk
NVO
+$465M
5
CL icon
Colgate-Palmolive
CL
+$458M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 14.45%
2 Healthcare 11.94%
3 Consumer Discretionary 11.58%
4 Consumer Staples 10.68%
5 Financials 9.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ITP icon
2676
IT Tech Packaging
ITP
$2.96M
$64K ﹤0.01%
+4,240
New +$71.5K
GIG
2677
DELISTED
GigPeak, Inc.
GIG
$62K ﹤0.01%
+47,500
New +$55.9K
SBLK icon
2678
Star Bulk Carriers
SBLK
$3.02B
$60K ﹤0.01%
+2,205
New +$67.4K
CERE
2679
DELISTED
CERES, INC. COMMON STOCK NEW
CERE
$60K ﹤0.01%
+2,388
New +$49.7K
IDIX
2680
DELISTED
IDENIX PHARMACEUTICALS INC
IDIX
$59K ﹤0.01%
+16,466
New +$67.3K
UUU icon
2681
Universal Safety Products Inc
UUU
$9.54M
$58K ﹤0.01%
+10,700
New +$52.2K
GNMX
2682
DELISTED
Aevi Genomic Medicine Inc
GNMX
$58K ﹤0.01%
+15,300
New +$62.7K
CBMX
2683
DELISTED
CombiMatrix Corporation
CBMX
$57K ﹤0.01%
+1,198
New +$57.5K
GLDC
2684
DELISTED
GOLDEN ENTERPRISES
GLDC
$57K ﹤0.01%
+16,200
New +$56.7K
RDNT icon
2685
RadNet
RDNT
$4.84B
$56K ﹤0.01%
+21,000
New +$55.5K
FPP.WS
2686
DELISTED
FieldPoint Petroleum Corporation Common Stock Purchase Warrants
FPP.WS
$56K ﹤0.01%
+92,800
New +$64.9K
ACGN
2687
DELISTED
Aceragen Inc
ACGN
$54K ﹤0.01%
+612
New +$55.1K
PNTR
2688
DELISTED
Pointer Telocation Ltd.
PNTR
$54K ﹤0.01%
+13,700
New +$47K
HPJ
2689
DELISTED
Highpower International Inc
HPJ
$54K ﹤0.01%
+46,300
New +$48.9K
GNSS icon
2690
Genasys
GNSS
$74.2M
$53K ﹤0.01%
+46,900
New +$47.3K
RBPAA
2691
DELISTED
Royal Bancshares Of Pennsylvania Inc
RBPAA
$53K ﹤0.01%
+37,300
New +$53.1K
OCRX
2692
DELISTED
Ocera Therapeutics, Inc.
OCRX
$52K ﹤0.01%
+9,182
New +$57K
PATH
2693
DELISTED
NUPATHE INC COM STK
PATH
$52K ﹤0.01%
+17,017
New +$54.8K
TRMD
2694
DELISTED
TORM A/S AMERICAN DEPOSITARY SHARES
TRMD
$52K ﹤0.01%
+21,810
New +$48.9K
ALVR
2695
DELISTED
Alvarion Ltd
ALVR
$51K ﹤0.01%
+40,140
New +$102K
SMTX
2696
DELISTED
SMTC Corporation
SMTX
$50K ﹤0.01%
+24,900
New +$53.5K
ENVI
2697
DELISTED
ENVIVIO INC COM STK (DE)
ENVI
$50K ﹤0.01%
+24,900
New +$42.6K
BLRX
2698
BioLineRX
BLRX
$12.3M
$48K ﹤0.01%
+50
New +$51.8K
VCEL icon
2699
Vericel Corp
VCEL
$2.31B
$48K ﹤0.01%
+6,023
New +$72.4K
OXGN
2700
DELISTED
OXIGENE INC COM
OXGN
$47K ﹤0.01%
+17,585
New +$57.9K

Similar funds

Renaissance Technologies's Q2 2013 Portfolio in Review

Q2 2013 is the first quarter with a 13F filing on record for Renaissance Technologies, which disclosed 2,756 positions worth $38.1B. Its ten largest holdings account for 11% of the portfolio.

Its largest position is Eli Lilly: 12,326,205 shares worth $605M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, followed by Healthcare and Consumer Discretionary.

  • Renaissance Technologies's largest Q2 2013 buy was Eli Lilly: 12,326,205 shares worth $605M.
  • Renaissance Technologies's ten largest holdings make up 11% of its $38.1B portfolio in Q2 2013.
  • Renaissance Technologies disclosed 2,756 positions in Q2 2013, its first 13F filing on record.

Based on Renaissance Technologies's 13F filing for Q2 2013, filed 12 Aug 2013.